- Home
- EIC vs SRZN Comparison
EIC vs SRZN Comparison
Compare EIC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | SRZN |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.7M | 210.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EIC | SRZN |
|---|---|---|
| Price | $9.75 | $27.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $14.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 182.6K | 70.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 14.01% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.27 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.44 | $7.11 |
| 52 Week High | $15.89 | $29.60 |
Technical Indicators
Market Signals| Indicator | EIC | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 60.36 |
| Support Level | N/A | $11.66 |
| Resistance Level | $11.34 | N/A |
| Average True Range (ATR) | 0.22 | 2.29 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 45.56 | 78.29 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).